Biotech Archives - MarketWise

May 7, 2026

Amgen’s Stock Has Stumbled Despite Strong Earnings. Here’s What Investors Are Watching Right Now

Amgen delivered strong quarterly results, yet its stock has been falling. Explore the key reasons, including clinical setbacks, rising competition, and valuation concerns.

Read this issue

March 11, 2026

The public isn’t wild for this tech theme yet, but it’s just a matter of time

This overlooked tech theme could be the next big winner. Plus, a bullish biotech breakout and key signals from AI and market trends.

Read this issue

March 9, 2026

Why Trump wants this sector to soar

The past week has been generally unpleasant for most financial markets, but if you’re looking for some good news, look at the biotechnology sector. It just passed an important “stress test,” which is bullish.

Read this issue

February 17, 2026

Danaher Makes a Splash – What Investors Should Know About the $9.9 Billion Acquisition of Masimo

Danaher is acquiring Masimo in a $9.9 billion all-cash deal. Here’s what the acquisition means for DHR stock, Masimo’s Apple litigation, and long-term investors.

Read this issue

January 28, 2026

Big news in the great “AI Boom or AI Bust” debate

Big news in the great “AI Boom or AI Bust” debate as semiconductor stocks hit new highs, reinforcing the strength of the AI bull case while weighing both sides of this critical market trend.

Read this issue

Biotech

Article Date Range

Author

Categories

Amgen’s Stock Has Stumbled Despite Strong Earnings. Here’s What Investors Are Watching Right Now

The public isn’t wild for this tech theme yet, but it’s just a matter of time

Why Trump wants this sector to soar

Danaher Makes a Splash – What Investors Should Know About the $9.9 Billion Acquisition of Masimo

Big news in the great “AI Boom or AI Bust” debate